Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor

Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor

Several reports have indicated that the chemokine receptor CCR5 and its ligands, especially CCL5 (formerly known as RANTES), may play a role in the pathogenesis of psoriasis. The purpose of this investigation was to examine the expression of CCR5 and its ligands in chronic plaque psoriasis and to ev...

Full description

Bibliographic Details
Main Authors: de Groot, Marjan, Teunissen, Marcel B. M., Ortonne, Jean P., Lambert, Julien R., Naeyaert, Jean M., Picavet, Daisy I., Arreaza, M. Gladys, Simon, Jason S., Kraan, Maarten, Bos, Jan D., de Rie, Menno A.
Format: Online
Language:English
Published: Springer-Verlag 2007
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950346/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950346/

Similar Items